Trading / Browse Companies / ANDE stock

ANDE Stock

ande.comBioTechFounded: 2004Funding to Date: $128.92MM

ANDE is the developer of rapid DNA analysis technology designed to help reduce crime, exonerate innocent, monitor borders, and reunite families.

Buy or sell ANDE stock
Register for Details

For more details on financing and valuation for ANDE, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

OverviewFinancingsValuation

Team

Management Team

George Heinrichs
Chief Executive Officer & Board Member
John Rose
Chief Financial Officer
Richard Selden
Founder, Chairman & Chief Scientific Officer
Mary Consalvi
General Counsel

Board Members

Beth Kronfeld
ANDE
David Kronfeld
ANDE
George Heinrichs
ANDE
Richard Selden
ANDE

Other companies like ANDE in the BioTech sector

Mammoth Biosciences
Sector
BioTech
Last Round Est. Valuation
$1.08B
Ginkgo Bioworks
Sector
BioTech
Last Round Est. Valuation
$4.89B
PROCEPT BioRobotics
Sector
BioTech
Last Round Est. Valuation
$872.62MM
Synthego
Sector
BioTech
Last Round Est. Valuation
$486.63MM
eFFECTOR Therapeutics
Sector
BioTech
Last Round Est. Valuation
$186.12MM
Human Longevity
Sector
BioTech
Last Round Est. Valuation
$50.4MM
Grail
Sector
BioTech
Last Round Est. Valuation
$4.26B
Arsenal Biosciences
Sector
BioTech
Last Round Est. Valuation
$185MM
Caris Life Sciences
Sector
BioTech
 
 

Trending Companies

Frequently Asked Questions